27127/34351US=2 / Biol/Mol
Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE

27128/34351US=1-B / Farmacologia
Petri WA Jr. Chemotherapy of tuberculosis, mycobacterium avium complex disease, and leprosy. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1203-23. ISBN 978-0-071-142280-3.

QUIMIOTERAPIA DA TUBERCULOSE; DOENCA DE COMPLEXO DE MYCOBACTERIUM AVIUM; LEPRA; DROGAS PARA A TUBERCULOSE; DROGAS PARA A LEPRA

27129/34351US=2 / Biol/Mol
Saelens X, Festjens N, Walle LV, Vandenabeele P. Mitochondria: role of mitochondrial proteins in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 183-221. ISBN 978-3-527-31237-5.

APOPTOSE; PAPEL DAS PROTEINAS MITOCONDRIAIS; FAMILIA BCL-2; PERMEABILIZACAO DA MEMBRANA MITOCONDRIAL; MUTACOES APOPTOTICAS; CITOCROMO C

27130/34351US=2 / Biol/Mol
Suzuki Y, Takahashi R. Mitochondria: omi/HtrA2: a mitochondrial serine protease regulating cellular life and death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 222-32. ISBN 978-3-527-31237-5.

MITOCONDRIAS; OMI/HTRA2; SERINA PROTEASE MITOCONDRIAL; MORTE CELULAR

27131/34351US=1-B / Farmacologia
Bennett JE. Antimicrobial agentes: antifungal agents. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1225-41. ISBN 978-0-071-142280-3.

AGENTES ANTIMICROBIANOS; AGENTES ANTIFUNGICOS; ANTIFUNGICOS SISTEMICOS

27132/34351US=2 / Biol/Mol
Vahsen N, Kroemer G. Mitochondria: apoptosis-inducing factor. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 233-55. ISBN 978-3-527-31237-5.

MITOCONDRIAS; FATOR DE INDUCAO DE APOPTOSE; ISOFORMES

27133/34351US=2 / Biol/Mol
Adrain C, Martin SJ. Effector systems: caspases: agents of defense and destruction. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 259-81. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; CASPASES; APOPTOSE

27134/34351US=1-B / Farmacologia
Hayden FG. Antiviral agentes (nonretroviral). In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1242-71. ISBN 978-0-071-142280-3.

AGENTES ANTIVIRAIS; NAO RETROVIRAL; AGENTES ANTIHERPESVIRUS; AGENTES ANTI-GRIPE; AGENTES ANTIHEPATITIS

27135/34351US=2 / Biol/Mol
Cain K. Effector systems: the role of the apoptosome and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 282-313. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; TERAPIA APOPTOSSOMO; CANCER; CITOCROMO C; CASPASE

27136/34351US=2 / Biol/Mol
Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE

27137/34351US=2 / Biol/Mol
Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER

27138/34351US=1-B / Farmacologia
Flexner C. Antiretroviral agents and treatment of HIV infection. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1273-1314. ISBN 978-0-071-142280-3.

AGENTES DE TRATAMENTO; INFECCAO POR HIV ANTI-RETROVIRAIS; HISTORIA DA TERAPIA ANTI-RETROVIRAL; QUIMIOTERAPIA DO HIV; NUCLEOSIDEOS; INIBIDORES DA TRANSCRIPTASE REVENSE NUCLEOTIDOS; INIBIDORES NAO-NUCLEOSIDEOS DA TRANSCRIPTASE REVERSA; INIBIDORES DA PROTEASE DO HIV; INIBIDORES DE ENTRADA

27139/34351US=2 / Biol/Mol
Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR

27140/34351US=2 / Biol/Mol
Holcik M. IAPs: inhibitor of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 403-26. ISBN 978-3-527-31237-5.

IAPS; INIBIDORES DE PROTEINAS DE APOPTOSE

27141/34351US=2 / Biol/Mol
Altieri DC. IAPs: targeting the survivin pathway for rational cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 427-42. ISBN 978-3-527-31237-5.

IAPS; SURVIVINA; INIBIDOR DE PROTEINA A APOPTOSE

27142/34351US=2 / Biol/Mol
Greten FR, Karin M. Survival pathways: nuclear factor-kB in apoptosis and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 443-61. ISBN 978-3-527-31237-5.

CANCER; FATOR NUCLEAR-KB; APOPTOSE; CARCINOGENESE

27143/34351US=1-B / Farmacologia
Chabner BA, Amrein PC, Druker BJ, Michaelson MD, Mitsiades CS, Doss PE, Ryan DP, Ramachandra S, Richardson PG, Supko JG, Wilson WH. Antineoplastic agents. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1315-1403. ISBN 978-0-071-142280-3.

AGENTES ANTINEOPLASICOS; AGENTES ALQUILANTES; TOXICIDADES DOS AGENTES ALQUILANTES; DIVERSAS DROGAS ALQUILANTES; ANALOGOS DE ACIDO FOLICO; PIRIMIDINA ANALOGOS; ANALOGOS DA CITIDINA; ANALOGOS DE PURINAS; DROGAS ANTIMITOTICAS; ANTIBIOTICOS; EPIPODOFILOTOXINAS; ENZIMAS

27144/34351US=2 / Biol/Mol
Scheid MP, Woodgett JR. Survival pathways: cell survival through phosphoinositide 3-kinase and protein kinase B. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 463-89. ISBN 978-3-527-31237-5.

SOBREVIVENCIA CELULAR; FOSFATIDILINOSITOL 3-QUINASE; PROTEINA QUINASE B; MTOR

27145/34351US=1-B / Farmacologia
Krensky AM, Vinventi F, Bennett WM. Immunosuppressants, tolerogens, and immunostimulants. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1405-1431. ISBN 978-0-071-142280-3.

RESPOSTA IMUNE; IMUNOSSUPRESSORES; TOLEROGENS; IMUNOESTIMULANTES; IMUNOTERAPIA

27146/34351US=2 / Biol/Mol
Drexler HCA, Hekman GM, Albert S, Rapp UR. Survival pathways: survival regulation by ras and raf. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 490-513. ISBN 978-3-527-31237-5.

CONTROLE DE SOBREVIVENCIA; RAS; RAF; APOPTOSE

Primeira | Anterior | Próxima | Última